JPWO2021092476A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021092476A5
JPWO2021092476A5 JP2022526119A JP2022526119A JPWO2021092476A5 JP WO2021092476 A5 JPWO2021092476 A5 JP WO2021092476A5 JP 2022526119 A JP2022526119 A JP 2022526119A JP 2022526119 A JP2022526119 A JP 2022526119A JP WO2021092476 A5 JPWO2021092476 A5 JP WO2021092476A5
Authority
JP
Japan
Prior art keywords
cell
nucleic acid
subject
acid molecules
variants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022526119A
Other languages
English (en)
Japanese (ja)
Other versions
JP7825272B2 (ja
JP2023501376A5 (https=
JP2023501376A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/059526 external-priority patent/WO2021092476A1/en
Publication of JP2023501376A publication Critical patent/JP2023501376A/ja
Priority to JP2023208448A priority Critical patent/JP7807089B2/ja
Publication of JP2023501376A5 publication Critical patent/JP2023501376A5/ja
Publication of JPWO2021092476A5 publication Critical patent/JPWO2021092476A5/ja
Application granted granted Critical
Publication of JP7825272B2 publication Critical patent/JP7825272B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022526119A 2019-11-06 2020-11-06 核酸分子を分析するための方法およびシステム Active JP7825272B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023208448A JP7807089B2 (ja) 2019-11-06 2023-12-11 核酸分子を分析するための方法およびシステム

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962931688P 2019-11-06 2019-11-06
US62/931,688 2019-11-06
PCT/US2020/059526 WO2021092476A1 (en) 2019-11-06 2020-11-06 Methods and systems for analyzing nucleic acid molecules

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023208448A Division JP7807089B2 (ja) 2019-11-06 2023-12-11 核酸分子を分析するための方法およびシステム

Publications (4)

Publication Number Publication Date
JP2023501376A JP2023501376A (ja) 2023-01-18
JP2023501376A5 JP2023501376A5 (https=) 2023-12-20
JPWO2021092476A5 true JPWO2021092476A5 (https=) 2023-12-20
JP7825272B2 JP7825272B2 (ja) 2026-03-06

Family

ID=75848071

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022526119A Active JP7825272B2 (ja) 2019-11-06 2020-11-06 核酸分子を分析するための方法およびシステム
JP2023208448A Active JP7807089B2 (ja) 2019-11-06 2023-12-11 核酸分子を分析するための方法およびシステム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023208448A Active JP7807089B2 (ja) 2019-11-06 2023-12-11 核酸分子を分析するための方法およびシステム

Country Status (14)

Country Link
US (14) US20210172022A1 (https=)
EP (3) EP4527945A3 (https=)
JP (2) JP7825272B2 (https=)
KR (1) KR20220094218A (https=)
CN (3) CN118374597A (https=)
AU (1) AU2020378435A1 (https=)
BR (1) BR112022008752A2 (https=)
CA (1) CA3156589A1 (https=)
DE (1) DE112020005433T5 (https=)
DK (1) DK4055187T3 (https=)
ES (1) ES3041276T3 (https=)
GB (4) GB2613427B (https=)
MX (1) MX2022005588A (https=)
WO (1) WO2021092476A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2970916C (en) 2014-03-14 2025-02-04 Caredx, Inc. METHODS FOR MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENT
WO2021092476A1 (en) 2019-11-06 2021-05-14 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for analyzing nucleic acid molecules
US11783912B2 (en) 2021-05-05 2023-10-10 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for analyzing nucleic acid molecules
KR20230064172A (ko) * 2021-11-03 2023-05-10 주식회사 지씨지놈 세포유리 핵산단편 위치별 서열 빈도 및 크기를 이용한 암 진단 방법
MX2024006820A (es) * 2021-12-15 2024-08-15 Univ Johns Hopkins Mutacion del genoma completo de molecula unica y perfiles de fragmentacion de acido desoxirribonucleico (adn) libre de celula.
CN114974421B (zh) * 2022-05-20 2024-04-30 南开大学 基于扩散-降噪的单细胞转录组测序数据补插方法及系统
KR20230172174A (ko) * 2022-06-15 2023-12-22 주식회사 지씨지놈 무세포 핵산의 단일염기변이를 이용한 암 진단 및 암 종 예측방법
CN115181800B (zh) * 2022-07-11 2025-06-13 南京世和基因生物技术股份有限公司 基因标志物在非小细胞肺癌预后效果预测中的应用、预测装置以及计算机可读取介质
GB202212094D0 (en) * 2022-08-19 2022-10-05 Inivata Ltd Method of detecting cancer DNA in a sample
CN116466085A (zh) * 2022-11-28 2023-07-21 中国人民解放军海军军医大学第三附属医院 一种四基因的生物标志物组合及其在肝癌治疗中的应用
KR102630597B1 (ko) * 2023-08-22 2024-01-29 주식회사 지놈인사이트테크놀로지 종양 정보를 활용한 미세 잔존 질환 탐지 방법 및 장치
US20250140343A1 (en) * 2023-10-30 2025-05-01 Myriad Women's Health, Inc. Methods for improving minimal residual disease assays
WO2025245136A1 (en) * 2024-05-22 2025-11-27 Foresight Diagnostics Inc. Methods and systems for adjuvant therapy
WO2026019737A1 (en) * 2024-07-16 2026-01-22 Myriad Women's Health, Inc. Targeted depletion sequencing for use in minimum residual disease assays
WO2026072949A1 (en) * 2024-09-27 2026-04-02 Roche Sequencing Solutions, Inc. Multi-modal risk stratification of minimum residual disease

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA241076A (en) 1924-06-24 Carter Formby King Otis Calculating apparatus
CA233975A (en) 1923-09-04 Rightmire Franklin Anti-skid chain tightener
CA188298A (en) 1918-04-08 1919-01-14 William H. Bot Grain separator
US5804396A (en) 1994-10-12 1998-09-08 Sugen, Inc. Assay for agents active in proliferative disorders
US6171856B1 (en) 1997-07-30 2001-01-09 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
DE10032165A1 (de) 2000-07-01 2002-01-10 Beiersdorf Ag Verwendung von physiologisch verträglichen Sulfinsäuren als Antioxidans oder Radikalfänger in kosmetischen oder dermatologischen Zubereitungen
NZ532780A (en) 2001-12-21 2006-10-27 Wellcome Trust Isolated naturally occurring mutant human B-Raf polypeptides and nucleic acids encoding them
CN101501211A (zh) 2004-03-31 2009-08-05 综合医院公司 测定癌症对表皮生长因子受体靶向性治疗反应性的方法
US7393665B2 (en) 2005-02-10 2008-07-01 Population Genetics Technologies Ltd Methods and compositions for tagging and identifying polynucleotides
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
WO2011103236A2 (en) 2010-02-18 2011-08-25 The Johns Hopkins University Personalized tumor biomarkers
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
CA2811185C (en) 2010-09-21 2020-09-22 Population Genetics Technologies Ltd. Increasing confidence of allele calls with molecular counting
KR20190002733A (ko) 2010-12-30 2019-01-08 파운데이션 메디신 인코포레이티드 종양 샘플의 다유전자 분석의 최적화
ES2625288T3 (es) 2011-04-15 2017-07-19 The Johns Hopkins University Sistema de secuenciación segura
DK2814959T3 (en) 2012-02-17 2018-04-23 Hutchinson Fred Cancer Res COMPOSITIONS AND PROCEDURES FOR EXACTLY IDENTIFYING MUTATIONS
EP3744857A1 (en) 2012-03-20 2020-12-02 University Of Washington Through Its Center For Commercialization Methods of lowering the error rate of massively parallel dna sequencing using duplex consensus sequencing
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
GB2533006B (en) 2012-09-04 2017-06-07 Guardant Health Inc Systems and methods to detect copy number variation
US10876152B2 (en) 2012-09-04 2020-12-29 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
CN105190656B (zh) 2013-01-17 2018-01-16 佩索纳里斯公司 用于遗传分析的方法和系统
EP3885446A1 (en) 2013-02-01 2021-09-29 The Regents of The University of California Methods for genome assembly and haplotype phasing
CN113337604A (zh) 2013-03-15 2021-09-03 莱兰斯坦福初级大学评议会 循环核酸肿瘤标志物的鉴别和用途
ES2660989T3 (es) 2013-12-28 2018-03-27 Guardant Health, Inc. Métodos y sistemas para detectar variantes genéticas
EP3957749A1 (en) 2014-04-21 2022-02-23 Natera, Inc. Detecting tumour specific mutations in biopsies with whole exome sequencing and in cell-free samples
WO2015169947A1 (en) * 2014-05-09 2015-11-12 Lifecodexx Ag Detection of dna that originates from a specific cell-type and related methods
AU2015269103B2 (en) * 2014-06-06 2021-12-23 Cornell University Method for identification and enumeration of nucleic acid sequence, expression, copy, or DNA methylation changes, using combined nuclease, ligase, polymerase, and sequencing reactions
MX2016016904A (es) * 2014-06-26 2017-03-27 10X Genomics Inc Analisis de secuencias de acidos nucleicos.
EP3191628B1 (en) 2014-09-12 2022-05-25 The Board of Trustees of the Leland Stanford Junior University Identification and use of circulating nucleic acids
WO2016049878A1 (zh) * 2014-09-30 2016-04-07 深圳华大基因科技有限公司 一种基于snp分型的亲子鉴定方法及应用
CN107002131B (zh) 2014-11-12 2022-04-29 尼欧基因组学实验室股份有限公司 作为确认骨髓增生异常综合征诊断的可靠测试的外周血血浆dna深度测序
WO2016130578A1 (en) 2015-02-09 2016-08-18 10X Genomics, Inc. Systems and methods for determining structural variation and phasing using variant call data
ES2969767T3 (es) 2015-05-01 2024-05-22 Guardant Health Inc Métodos de diagnóstico
CA3002740A1 (en) 2015-10-19 2017-04-27 Dovetail Genomics, Llc Methods for genome assembly, haplotype phasing, and target independent nucleic acid detection
WO2017075436A1 (en) 2015-10-30 2017-05-04 New England Biolabs, Inc. Compositions and methods for determining modified cytosines by sequencing
US10260088B2 (en) 2015-10-30 2019-04-16 New England Biolabs, Inc. Compositions and methods for analyzing modified nucleotides
EP3384050A4 (en) 2015-12-03 2019-07-31 Alfred Health MONITORING THE TREATMENT OR PROGRESSION OF MYELOMA
PL3387152T3 (pl) 2015-12-08 2022-05-09 Twinstrand Biosciences, Inc. Ulepszone adaptory, sposoby i kompozycje do sekwencjonowania dupleksowego
CN109072309B (zh) 2016-02-02 2023-05-16 夸登特健康公司 癌症进化检测和诊断
US11479878B2 (en) * 2016-03-16 2022-10-25 Dana-Farber Cancer Institute, Inc. Methods for genome characterization
US11299783B2 (en) 2016-05-27 2022-04-12 Personalis, Inc. Methods and systems for genetic analysis
GB2600627B (en) 2016-05-27 2022-12-07 Personalis Inc Personalized genetic testing
US9850523B1 (en) 2016-09-30 2017-12-26 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
WO2018081161A1 (en) 2016-10-24 2018-05-03 Biomatrica, Inc. Stabilization of nucleic acids on paper
EP4134444B1 (en) 2017-03-23 2024-10-02 University of Washington Methods for targeted nucleic acid sequence enrichment with applications to error corrected nucleic acid sequencing
US11342047B2 (en) * 2017-04-21 2022-05-24 Illumina, Inc. Using cell-free DNA fragment size to detect tumor-associated variant
US11542540B2 (en) 2017-06-16 2023-01-03 Life Technologies Corporation Control nucleic acids, and compositions, kits, and uses thereof
EP3654763A4 (en) 2017-06-28 2021-06-09 Dow Agrosciences LLC PLANT PROMOTER FOR TRANSGENIC EXPRESSION
EP3685386A1 (en) 2017-09-20 2020-07-29 Guardant Health, Inc. Methods and systems for differentiating somatic and germline variants
EP3762512A1 (en) 2018-03-06 2021-01-13 Cancer Research Technology Limited Improvements in variant detection
CN109337983A (zh) * 2018-11-29 2019-02-15 优葆优保健康科技(宁波)有限公司 检测人甲状腺癌循环肿瘤dna的探针组合及其捕获测序系统
EP3914736B1 (en) * 2019-01-25 2023-12-20 Grail, LLC Detecting cancer, cancer tissue of origin, and/or a cancer cell type
KR102526916B1 (ko) * 2019-04-05 2023-05-02 주식회사 제놉시 Cfdna를 이용한 위암 진단방법
CN110055312B (zh) * 2019-04-09 2022-11-15 嘉兴雅康博医学检验所有限公司 用于检测egfr基因c797s和t790m顺反式突变的引物、探针及试剂盒
WO2021003485A1 (en) 2019-07-03 2021-01-07 The Board Of Trustees Of The Leland Stanford Junior University Methods to assess clinical outcome based upon updated probabilities and treatments thereof
WO2021092476A1 (en) 2019-11-06 2021-05-14 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for analyzing nucleic acid molecules
AU2021225854A1 (en) 2020-02-24 2022-10-13 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for protecting nucleic-acid molecules
JP2024519501A (ja) 2021-05-05 2024-05-14 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 核酸分子を分析するための方法およびシステム
US11783912B2 (en) 2021-05-05 2023-10-10 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for analyzing nucleic acid molecules

Similar Documents

Publication Publication Date Title
GB2595193A (en) Methods and systems for analyzing nucleic acid molecules
US20210065842A1 (en) Systems and methods for determining tumor fraction
US10457988B2 (en) MiRNAs as diagnostic markers
JPWO2021092476A5 (https=)
US20190338362A1 (en) Methods for non-invasive prenatal determination of aneuploidy using targeted next generation sequencing of biallelic snps
CN110117652A (zh) 肝癌早期诊断方法
CN119546780A (zh) 用于治疗监测的甲基化无细胞dna的分子计数
US10161004B2 (en) Diagnostic miRNA profiles in multiple sclerosis
CN108300787A (zh) 特异甲基化位点作为乳腺癌早期诊断标志物的应用
JP2024530154A (ja) 体細胞変異と異常にメチル化された断片との同時発生
KR20240015624A (ko) 게놈 전체 cfdna 단편화 프로파일을 이용한 암을 검출하는 방법
EP4464792A1 (en) Non-invasive in-vitro method of diagnosis
KR20260011755A (ko) 체세포 돌연변이 검출을 위한 비침습적 시험관 내 방법
WO2020194057A1 (en) Biomarkers for disease detection
US20230099193A1 (en) Personalized cancer liquid biopsies using primers from a primer bank
WO2023147445A2 (en) Cell-free rna biomarkers for the detection of cancer or predisposition to cancer
CN108531593A (zh) 特异甲基化位点作为乳腺癌复发诊断标志物的应用
CN113584171A (zh) 基因突变位点的用途及突变位点检测方法
KR102152893B1 (ko) 간세포암종 특이 mlh1 유전자에 대한 순환 종양 dna 변이 검출 용도
CN115772566B (zh) 用于辅助检测肺癌体细胞erbb2基因突变的甲基化生物标记物及其应用
EP4628598A1 (en) Dna methylation marker for determination of t-status of cancer
HK40064341A (en) Methods and systems for analyzing nucleic acid molecules
EP3790995B1 (en) Method of cancer prognosis by assessing tumor variant diversity by means of establishing diversity indices
WO2022188776A1 (zh) 可用于胃癌her2伴随诊断的基因甲基化标记物或其组合和应用
HK40080902A (en) Gene methylation markers or combinations thereof for concomitant diagnosis of her2 in gastric carcinoma, and use thereof